Mehra Uneek
- SEC CIK
- 0001881504
No open-market purchases or sales filed in the past year.
Current role at each company
- BBOT BridgeBio Oncology Therapeutics, Inc.Other: Former Officeras of May 5, 2026
- FDMT 4D Molecular Therapeutics, Inc.See Remarksas of Mar 10, 2025
- MYOV Myovant Sciences Ltd.Principal Financial Officeras of Mar 10, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mehra Uneek as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MYOV Myovant Sciences Ltd.
Principal Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Mehra UneekPrincipal Financial Officer | SSale | −2.24K | $26.75 | −$59.9K | −1.1%202.7K after | |
| Sep 20, 2022 (view filing) | Sep 16 | 4 days | Mehra UneekPrincipal Financial Officer | SSale | −9.24K | $18.86 | −$174.3K | −4.3%204.9K after |